
Pulsenmore fell 80.8% from $7.36 to $1.41, behind the S&P 500's +8.0%. Its worst day was Jan 22 (−18.8%), and its low came Nov 13 at $1.38.
Jan 21, 2026 – Nov 16, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.77 was reported on $12.5M revenue.
+0.6% · S&P 500 −0.3%
Pulsenmore shares rose 27.3%, while the S&P 500 rose 0.6%.
+27.3% · S&P 500 +0.6%
Story events cover the past 12 months · Times ET
Through the collaboration, Ouma Health will incorporate Pulsenmore’s FDA-authorized home ultrasound platform as part of its virtual maternity care platform, enabling clinicians to extend prenatal ultrasound
+93.8%, the year's best day, on 58M shares, the year's heaviest volume · S&P 500 0.0%
EPS of $-1.83 was reported on $2.0M revenue.
+1.9% · S&P 500 −0.3%
Where it ended: a close of $1.41 on Nov 16, 2026.
Nothing in the past 12 months.
All PLSM analyst actionsNothing in the past 12 months.
All PLSM dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for PLSM and SPY from Benzinga historical bars. Not investment advice.